Skip to main navigation Skip to search Skip to main content

correction to: Imidazole Type Antifungal Drugs Are Effective Colistin Adjuvants That Resensitize Colistin-Resistant Enterobacteriaceae (Adv. Therap., (2020), 3, (2000084), 10.1002/adtp.202000084)

  • Chen Xu
  • , Kaichao Chen
  • , Kin Fai Chan
  • , Edward Wai Chi Chan
  • , Xuyun Guo
  • , Hoi Yee Chow
  • , Guangming Zhao
  • , Ping Zeng
  • , Miaomiao Wang
  • , Ye Zhu
  • , Xuechen Li
  • , Kwok Yin Wong
  • , Sheng Chen*

Research output: Journal article publicationComment/debate/erratum

Abstract

The originally published Figure 7 was inadvertently a copy of Figure S5. The correct figure 7 reports the data for mcr-1-bearing E. coli rather than E. coli J53. The conclusions of the work are not affected by this error. The authors apologizes for any inconvenience caused. 1 Figure (Figure presented.).

Original languageEnglish
Article number2000182
JournalAdvanced Therapeutics
Volume3
Issue number12
DOIs
Publication statusPublished - Dec 2020

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology
  • Pharmaceutical Science
  • Genetics(clinical)
  • Biochemistry, medical
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'correction to: Imidazole Type Antifungal Drugs Are Effective Colistin Adjuvants That Resensitize Colistin-Resistant Enterobacteriaceae (Adv. Therap., (2020), 3, (2000084), 10.1002/adtp.202000084)'. Together they form a unique fingerprint.

Cite this